CDLX

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 61.9 M63.25 M52.03 M66.77 M34.32 M36.88 M 190 M Gross profit 61.9 M63.25 M52.03 M61.56 M34.32 M36.88 M 184.79 M Operating expenses 75.98 M76.04 M120.89 M79.04 M42.59 M24.5 M 267.02 M Selling/general/admin expenses 26.53 M24.24 M18.72 M20.46 M15.04 M14.46 M 68.68 M Research & development 11.71 M11.29 M8.8 M10.82 M6.43 M5.54 M 31.59 M Operating income -14.08 M-12.79 M-68.85 M-12.28 M-8.27 M-5.44 M -94.85 M Non-Operating Income, Total 797 K3.51 M-3.82 M-2.16 M-5.52 M-3.22 M -14.72 M Interest expense, net of interest capitalized 2.4 M2.4 M2.9 M-18.3 M2.8 M2.5 M -10.1 M Non-Operating Income, excl. Interest Expenses -1.83 M-1.94 M-4.91 M16.16 M-6.62 M-5.88 M -1.25 M Unusual income/expense 2.63 M5.45 M-1.81 M-17 K-1.71 M165 K -3.37 M Pretax income -13.28 M-9.28 M-72.67 M-14.43 M-13.8 M-8.66 M -109.56 M Equity in earnings —————— — Taxes 0——-1.01 M00 — Non-controlling/minority interest —————— — After tax other income/expense 2.62 M5.46 M-1.82 M-8 000-1.76 M181 K -3.42 M Net income before discontinued operations -16.25 M-9.28 M-72.67 M-8.25 M-13.8 M-8.66 M -103.38 M Discontinued operations 2.96 M———9.32 M-6.22 M — Net income -13.28 M-9.28 M-72.67 M-8.25 M-4.48 M-14.88 M -100.28 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -13.28 M-9.28 M-72.67 M-8.25 M-4.48 M-14.88 M -100.28 M Basic earnings per share (Basic EPS) -2.6-1.8-13.6-1.5-0.8-2.58 -18.48 Diluted earnings per share (Diluted EPS) -2.6-1.8-13.6-1.5-0.82-2.58 -18.5 Average basic shares outstanding 5.19 M5.28 M5.35 M5.31 M5.49 M5.76 M — Diluted shares outstanding 5.19 M5.28 M5.35 M5.31 M5.49 M5.76 M — EBITDA -7.79 M-6.51 M-62.38 M-6.07 M-3.86 M-1.38 M -73.69 M EBIT -14.08 M-12.79 M-68.85 M-12.28 M-8.27 M-5.44 M -94.85 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 6.29 M6.28 M6.47 M6.21 M4.42 M4.06 M 21.16 M